
Rather than attempting to build adult teeth from their constituent cells, Sharpe’s group replicated the natural processes involved in embryonic tooth development, focusing on the reciprocal interactions between the epithelium and mesenchyme10.Recombinations between mesenchyme created in vitro(by aggregation of non dental cultured cells from different cell sources) and embryonic oral epithelium collected from mouse embryos at 10th embryonic day(E10) , stimulated an odontogenic response in the mesenchyme. When such explants were transferred intact into adult renal capsules, they developed into teeth (crowns) with associated bone and soft tissues5.
The results offer important insights into tooth development and suggest that stem cells derived from adult bone marrow can take place of dental mesenchyme2 and the odontogenic process can be initiated in non dental cells of different origins10. Bone and soft tissues can be formed from non dental cell populations consisting entirely of purified stem cells or from heterogeneous population such as bone marrow derived cells10. But no suitable source of epithelial components has yet been found to replace the embryonic oral epithelium2.
Many years of experiments have established that embryonic epithelium12 contains a unique set of signals for odontogenesis that disappear from the mouth after birth. Sharpe’s group is continuing to seek an effective population of substitute cells that could be derived from an adult source5.
The teeth obtained from Sharpe’s group were in the normal size range for mouse teeth and showed earliest signs of root formation. Though it was doubtable whether such explants could also form teeth in the mouth. In embryonic jaw, soft tissues, teeth and bone, all are developing together without external stresses such as chewing and talking, where as it was not the case in adult jaws.
Sharpe group extracted tooth buds from embryonic mice (E14.5), then transplanted them into the diastema pockets between molars and incisors of adult mice. The mice were fed on soft diet and the transplants were monitored.5 The decalcified sections of the diastema, clearly revealed ectopic tooth formed at the site of transplantation. The teeth were in correct orientation, of appropriate size and attached to underlying bone by soft connective tissue. Thus, adult mouth could provide a suitable environment for tooth development10.
These approaches to tooth reconstitution using developing tissues are far from ready for patient application because it would be impractical to use human embryonic tissue. Strategic improvements are needed prior to clinical application to prevent immune rejection and to overcome ethical issues.
Though identification of stem cells in dental pulp and from exfoliated deciduous teeth also raises the possibility that a patient’s own tooth cells could be used to generate new tooth primordia13.
FUTURE TRENDS
Although in its infancy, tissue engineering approach can be used to bioengineer highly mineralized, anatomically correct replacement tooth tissues, reflecting its need for alternative therapies to treat variety of dental repair needs14. It is eventually possible to device clinically relevant therapies to replace damaged or lost dental tissues with biologic dental materials as a viable alternative to synthetic dental materials.
The research also provides intermediate products that can be used to augment existing synthetic dental repair materials eg, it is possible to use bioengineered dental materials to improve the function and duration of currently used titanium implants to underlying alveolar bone via autologous bioengineered periodontal ligament would help transmit mechanical forces of mastication from implants to underlying bone and might also help perform orthodontic treatments11.
Post natal stem cells isolated from developing wisdom teeth can regenerate functional tooth roots and periodontal ligaments that support synthetic crowns2.
We have entered an exciting era where the diverse fields of tissue engineering, material science, nano technology and stem cell biology have converged synergistically to provide unprecedented opportunities to characterize and manipulate signaling cascades, regulating tissue and organ regeneration.
The future for regenerative and tissue engineering applications to dentistry is one with immense potential, capable of bringing quantum advances in treatment for patients. The need for high quality research in the basic sciences is paramount to ensuring that the development of novel clinical treatment modalities is underpinned by robust mechanistic data and that such approaches are effective. This translational model epitomizes how dentistry should evolve and highlight the needs for close partnership between basic and clinical scientists.
Apart from the potential benefit to people who need new teeth, this research also offers two significant advantages for testing the concept of organ replacement15. Teeth are easily accessible and whereas our quality of life is greatly improved if we have them, we do not need our teeth to live. These may seem trivial points, but as the first wave of replacement organs start to make their way towards the clinic, teeth will serve as a crucial test of feasibility of different tissue engineering techniques. With organs essential to life, doctors will have no leeway to make mistakes, but mistakes with teeth would not be life threatening and could be corrected.
CHALLENGES
Tooth regeneration has also identified certain challenges. First, there are limits to the traditional principles of tissue engineering, related to whole tooth regeneration with correct morphology. Secondly, adult bone marrow cells can though alternate dental mesenchymal cells but no suitable substitute for embryonic epithelial compartment has yet been recognized.
Moreover, the techniques have not yet been established to control tooth size, shape and colour, particularly full human tooth size. Problems concerning the cell numbers obtained, host immune rejection and ethical issues of the use of human embryos still remains. Relevant ethical issues include the source of cells (patient’s own vs donated cells) and type (adult donor vs fetal cells).
CONCLUSION
The control of morphogenesis and cytodifferentiation is a challenge that necessitates a thorough understanding of the cellular and molecular events involved in development, repair and regeneration of teeth. The identification of several types of epithelial and mesenchymal stem cells in the tooth and the knowledge of molecules involved in stem cell fate is a significant achievement. Though, many problems remain to be addressed before considering the clinical use of these technologies. The use of animal cells for human diseases is restricted by immune rejection risks. It is possible to replace dental mesenchymal stem cells with stem cells of another origin, but not so is the case with epithelial stem cells.
A reliable source of epithelial stem cells remains to be determined. Alternative solutions such as use of artificial crowns are considered. The engineering of tridimensional matrices (either PLA polymers or collagen sponge) with a composition more or less similar to that of the organs to reconstruct and the addition of growth factors such as FGF or BMP might facilitate transplantation and differentiation of stem cells. However, engineering of tooth substitutes is hard to scale up, costly, time consuming and incompatible with the treatment of extensive tooth loss.
The field of tooth tissue engineering is one of the many areas likely to see significant progress in the next decade.